RMD

SEC source: 0001127602-24-022299 · form4.xml · nonDerivative · entry 2

Leong Justin · CIK 0001825782 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,878

F2 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthe grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

SEC source: 0001127602-24-022299 · form4.xml · nonDerivative · entry 1

Leong Justin · CIK 0001825782 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

F1 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest1/3each year on the anniversary of the grant.

SEC source: 0001127602-24-022296 · form4.xml · nonDerivative · entry 2

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,788

F2 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthe grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

SEC source: 0001127602-24-022296 · form4.xml · nonDerivative · entry 1

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,947

F1 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3each year on the anniversary of the grant.

SEC source: 0001127602-24-022294 · form4.xml · nonDerivative · entry 2

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 464,169

F2 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

SEC source: 0001127602-24-022294 · form4.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 460,071

F1 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

SEC source: 0001127602-24-022064 · form4.xml · derivative · entry 7

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,260

Underlying: ResMed Common Stock · 1,037 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

SEC source: 0001127602-24-022064 · form4.xml · derivative · entry 6

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: ResMed Common Stock · 6,877 shares

Expires 2025-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

SEC source: 0001127602-24-022064 · form4.xml · derivative · entry 5

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: ResMed Common Stock · 2,086 shares

Expires 2025-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 4

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,032

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

SEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 3

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

SEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 2

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

SEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 1

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.

SEC source: 0001127602-24-021984 · form4.xml · nonDerivative · entry 1

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,056

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.

SEC source: 0001127602-24-021919 · form4.xml · derivative · entry 5

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,049

Underlying: ResMed Common Stock · 14,683 shares

Expires 2024-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-021919 · form4.xml · nonDerivative · entry 2

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 440,799

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $210.31 - $219.11. The price reported above reflects the weighted average sale price.

SEC source: 0001127602-24-021919 · form4.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 455,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

SEC source: 0001127602-24-021754 · form4.xml · nonDerivative · entry 1

Leong Justin · CIK 0001825782 · President, Asia Latin America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,741

SEC source: 0001127602-24-020248 · form4.xml · nonDerivative · entry 1

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,056

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.

SEC source: 0001127602-24-020270 · form4.xml · derivative · entry 5

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,732

Underlying: ResMed Common Stock · 14,683 shares

Expires 2024-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-020270 · form4.xml · nonDerivative · entry 2

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 440,799

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $192.03 - $194.73. The price reported above reflects the weighted average sale price.

SEC source: 0001127602-24-020270 · form4.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 455,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

SEC source: 0001127602-24-018379 · form4.xml · nonDerivative · entry 1

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,056

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.

F2 · balance_after: Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.

SEC source: 0001127602-24-018325 · form4.xml · derivative · entry 5

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,415

Underlying: ResMed Common Stock · 14,683 shares

Expires 2024-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-018325 · form4.xml · nonDerivative · entry 2

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 440,799

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $210.58 - $213.86. The price reported above reflects the weighted average sale price.

F3 · balance_after: Includes 46.9596 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.

SEC source: 0001127602-24-018325 · form4.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 455,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

SEC source: 0001127602-24-018237 · form4.xml · nonDerivative · entry 1

Rider Michael J · CIK 0001982205 · Global General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,444

F1 · shares: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.

F2 · balance_after: Includes 103.91 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.

SEC source: 0001127602-24-016513 · form4.xml · nonDerivative · entry 1

Burt Carol · CIK 0001493926 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Carol Burt Hilliard Trust

Disclosed balance after: 14,892

F1 · kind: Represents a gift of shares to The Nature Concervancy, a charitable organization. Ms. Burt has no beneficial interest, control or dispositive power over the gifted shares.

SEC source: 0001127602-24-015779 · form4.xml · nonDerivative · entry 1

FARRELL PETER C · CIK 0001186102 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,204

F1 · kind: Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Trust. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.

SEC source: 0001127602-24-015777 · form4.xml · nonDerivative · entry 1

De Witte Jan · CIK 0001776929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,519

SEC source: 0001127602-24-016231 · form4a.xml · nonDerivative · entry 1

De Witte Jan · CIK 0001776929 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,519

F1 · kind: Amended to indicate that the transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.

SEC source: 0001127602-24-014978 · form4.xml · derivative · entry 3

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,883

Underlying: ResMed Common Stock · 12,000 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 8, 2024.

F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-014978 · form4.xml · nonDerivative · entry 2

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,056

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 8, 2024.

SEC source: 0001127602-24-014978 · form4.xml · nonDerivative · entry 1

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,056

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 8, 2024.

F2 · balance_after: Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.

SEC source: 0001127602-24-014727 · form4.xml · derivative · entry 8

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,098

Underlying: ResMed Common Stock · 13,507 shares

Expires 2024-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-014727 · form4.xml · derivative · entry 7

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,605

Underlying: ResMed Common Stock · 1,176 shares

Expires 2024-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year.

SEC source: 0001127602-24-014727 · form4.xml · nonDerivative · entry 3

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 440,752

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $215.71 - $217.08. The price reported above reflects the weighted average sale price.

SEC source: 0001127602-24-014727 · form4.xml · nonDerivative · entry 2

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 455,435

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

SEC source: 0001127602-24-014727 · form4.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,928

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

SEC source: 0001127602-24-013675 · form4.xml · nonDerivative · entry 1

Burt Carol · CIK 0001493926 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Carol Burt Hilliard Trust

Disclosed balance after: 14,939

F1 · kind: Gifted shares donated to Western Stock Show ASSN DBA National Western Stock Show, a 501(c)(3) charitable organization. Ms. Burt does not have dipositive power over the gifted shares.

SEC source: 0001127602-24-013617 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,446

SEC source: 0001127602-24-008924 · form4.xml · nonDerivative · entry 1

Rider Michael J · CIK 0001982205 · Global General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,607

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2023.

SEC source: 0001127602-24-008301 · form4.xml · nonDerivative · entry 1

Rider Michael J · CIK 0001982205 · Global General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,688

F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2023.

SEC source: 0001127602-24-006731 · form4.xml · nonDerivative · entry 2

FARRELL PETER C · CIK 0001186102 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,404

F2 · price: This transaction was executed in multiple trades at prices ranging from $182.41 - $183.07. The price reported above reflects the weighted average sale price.

SEC source: 0001127602-23-028436 · form4.xml · nonDerivative · entry 1

Sandercock Brett · CIK 0001346064 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,962

F1 · balance_after: Includes 47.925 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.

SEC source: 0001127602-23-028288 · form4.xml · nonDerivative · entry 1

Rider Michael J · CIK 0001982205 · Global General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,888

F1 · kind: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Rider has no beneficial interest, control or dispositive power over the gifted shares.

SEC source: 0001127602-23-028095 · form4a.xml · nonDerivative · entry 4

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,752

F3 · kind: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.

SEC source: 0001127602-23-028064 · form4.xml · nonDerivative · entry 1

Douglas Robert Andrew · CIK 0001352232 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,849

F1 · kind: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.

SEC source: 0001127602-23-028004 · form4.xml · nonDerivative · entry 1

Farrell Michael J. · CIK 0001485164 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,633

F1 · kind: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.

SEC source: 0001127602-23-028012 · form4.xml · nonDerivative · entry 1

Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,908

F1 · kind: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.